IT1246383B - Metodo per il mascheramento del sapore di farmaci - Google Patents

Metodo per il mascheramento del sapore di farmaci

Info

Publication number
IT1246383B
IT1246383B IT02005590A IT2005590A IT1246383B IT 1246383 B IT1246383 B IT 1246383B IT 02005590 A IT02005590 A IT 02005590A IT 2005590 A IT2005590 A IT 2005590A IT 1246383 B IT1246383 B IT 1246383B
Authority
IT
Italy
Prior art keywords
pct
taste
drugs
sec
masking
Prior art date
Application number
IT02005590A
Other languages
English (en)
Other versions
IT9020055A0 (it
IT9020055A1 (it
Inventor
Luigi Giovanni Mapelli
Marco Giuseppe Raffael Marconi
Marco Zema
Original Assignee
Eurand Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurand Int filed Critical Eurand Int
Publication of IT9020055A0 publication Critical patent/IT9020055A0/it
Priority to IT02005590A priority Critical patent/IT1246383B/it
Priority to JP50687791A priority patent/JP3193041B2/ja
Priority to US07/776,329 priority patent/US5409711A/en
Priority to PCT/EP1991/000689 priority patent/WO1991016043A1/en
Priority to CA002058946A priority patent/CA2058946C/en
Priority to ES91907609T priority patent/ES2048594T3/es
Priority to DE91907609T priority patent/DE69100991T2/de
Priority to AU76812/91A priority patent/AU635133B2/en
Priority to AT91907609T priority patent/ATE99927T1/de
Priority to EP91907609A priority patent/EP0477333B1/en
Priority to KR1019910701886A priority patent/KR0164863B1/ko
Priority to DK91907609.1T priority patent/DK0477333T3/da
Priority to SU915010753A priority patent/RU2085190C1/ru
Priority to PT97369A priority patent/PT97369B/pt
Priority to NZ237824A priority patent/NZ237824A/en
Priority to ZA912793A priority patent/ZA912793B/xx
Priority to IE127291A priority patent/IE64274B1/en
Publication of IT9020055A1 publication Critical patent/IT9020055A1/it
Application granted granted Critical
Publication of IT1246383B publication Critical patent/IT1246383B/it
Priority to HK12495A priority patent/HK12495A/xx
Priority to SA99191025A priority patent/SA99191025A/ar

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT02005590A 1990-04-17 1990-04-17 Metodo per il mascheramento del sapore di farmaci IT1246383B (it)

Priority Applications (19)

Application Number Priority Date Filing Date Title
IT02005590A IT1246383B (it) 1990-04-17 1990-04-17 Metodo per il mascheramento del sapore di farmaci
KR1019910701886A KR0164863B1 (ko) 1990-04-17 1991-04-09 약제학적 제형
SU915010753A RU2085190C1 (ru) 1990-04-17 1991-04-09 Твердая лекарственная форма для орального введения фармацевтически активных веществ, имеющих неблагоприятные органолептические свойства
PCT/EP1991/000689 WO1991016043A1 (en) 1990-04-17 1991-04-09 Pharmaceutical formulations
CA002058946A CA2058946C (en) 1990-04-17 1991-04-09 Formulations for the oral administration of drugs with masked taste
ES91907609T ES2048594T3 (es) 1990-04-17 1991-04-09 Formulaciones farmaceuticas.
DE91907609T DE69100991T2 (de) 1990-04-17 1991-04-09 Pharmazeutische formulierungen.
AU76812/91A AU635133B2 (en) 1990-04-17 1991-04-09 Pharmaceutical formulations
AT91907609T ATE99927T1 (de) 1990-04-17 1991-04-09 Pharmazeutische formulierungen.
EP91907609A EP0477333B1 (en) 1990-04-17 1991-04-09 Pharmaceutical formulations
JP50687791A JP3193041B2 (ja) 1990-04-17 1991-04-09 医薬製剤
DK91907609.1T DK0477333T3 (da) 1990-04-17 1991-04-09 Farmaceutiske præparater
US07/776,329 US5409711A (en) 1990-04-17 1991-04-09 Pharmaceutical formulations
PT97369A PT97369B (pt) 1990-04-17 1991-04-15 Processo para a preparacao de formulacoes farmaceutica na qual o sabor do medicamento e disfarcado por meio de revestimento do medicamento com uma membrana polimerica
NZ237824A NZ237824A (en) 1990-04-17 1991-04-15 Formulation for oral administration comprising a core of active ingredient coated by a polymer soluble at ph greater than 5 and containing an acidic compound to prevent dissolution of the coating in the mouth
ZA912793A ZA912793B (en) 1990-04-17 1991-04-15 Pharmaceutical formulations
IE127291A IE64274B1 (en) 1990-04-17 1991-04-16 Pharmaceutical formulations
HK12495A HK12495A (en) 1990-04-17 1995-01-26 Pharmaceutical formulations
SA99191025A SA99191025A (ar) 1990-04-17 1999-02-01 تراكيب صيدلية

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT02005590A IT1246383B (it) 1990-04-17 1990-04-17 Metodo per il mascheramento del sapore di farmaci

Publications (3)

Publication Number Publication Date
IT9020055A0 IT9020055A0 (it) 1990-04-17
IT9020055A1 IT9020055A1 (it) 1991-10-17
IT1246383B true IT1246383B (it) 1994-11-18

Family

ID=11163454

Family Applications (1)

Application Number Title Priority Date Filing Date
IT02005590A IT1246383B (it) 1990-04-17 1990-04-17 Metodo per il mascheramento del sapore di farmaci

Country Status (19)

Country Link
US (1) US5409711A (it)
EP (1) EP0477333B1 (it)
JP (1) JP3193041B2 (it)
KR (1) KR0164863B1 (it)
AT (1) ATE99927T1 (it)
AU (1) AU635133B2 (it)
CA (1) CA2058946C (it)
DE (1) DE69100991T2 (it)
DK (1) DK0477333T3 (it)
ES (1) ES2048594T3 (it)
HK (1) HK12495A (it)
IE (1) IE64274B1 (it)
IT (1) IT1246383B (it)
NZ (1) NZ237824A (it)
PT (1) PT97369B (it)
RU (1) RU2085190C1 (it)
SA (1) SA99191025A (it)
WO (1) WO1991016043A1 (it)
ZA (1) ZA912793B (it)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111388444A (zh) * 2020-03-18 2020-07-10 北京鑫开元医药科技有限公司 一种罗红霉素颗粒及其制备方法

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2704146B1 (fr) * 1993-04-19 1995-07-13 Cripdom Microcapsules d'acide acétylsalicylique à libération contrôlée.
AUPN969796A0 (en) * 1996-05-07 1996-05-30 F.H. Faulding & Co. Limited Taste masked liquid suspensions
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
DE19648576C2 (de) * 1996-11-23 1999-08-12 Lohmann Therapie Syst Lts Lutschtablette zur modifizierten Freisetzung von Wirkstoffen im Gastrointestinaltrakt
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
BR9705470A (pt) * 1997-11-12 1999-07-06 Ind Quimica E Farmaceutica Sch Processo para a preparação de uma composição farmaceutica oral composição farmaceutica oral e kit compreendendo uma composição farmacêutica
NZ333474A (en) * 1998-01-02 1999-06-29 Mcneil Ppc Inc A chewable tablet containing ibuprofen, fumaric acid and a non hydrocolloid binder e.g. a wax or a fat
UA65607C2 (uk) * 1998-03-04 2004-04-15 Орто-Макнейл Фармацевтикал, Інк. Фармацевтична композиція (варіанти) та спосіб її приготування
JP3143433B2 (ja) * 1998-07-07 2001-03-07 三基商事株式会社 マスキング組成物
FR2781152B1 (fr) * 1998-07-20 2001-07-06 Permatec Tech Ag Utilisation d'un polymere de type acrylique en tant qu'agent de desagregation
DE19835823A1 (de) * 1998-08-10 1999-10-07 Lindopharm Gmbh Pharmazeutische Zusammensetzung, Verfahren zu ihrer Herstellung und ihre Verwendung sowie aus ihr hergestellte wässerige Suspension
FR2793690B1 (fr) * 1999-03-30 2003-01-03 Cll Pharma Formulations pharmaceutiques en macrolides seuls ou associes a d'autres principes actifs et leur utilisation en therapeutique
BR0009557A (pt) 1999-04-06 2002-05-28 Ethypharm Lab Prod Ethiques Suspensão farmacêutica para beber de ibuprofeno
IN191239B (it) 1999-06-11 2003-10-11 Ranbaxy Lab Ltd
CN1288730A (zh) * 1999-09-07 2001-03-28 麦克内尔-Ppc股份有限公司 轻泻组合物
JP3718398B2 (ja) * 2000-01-11 2005-11-24 信越化学工業株式会社 フィルムコーティング剤及び経口固形製剤
US6508954B1 (en) * 2000-01-18 2003-01-21 Albemarle Corporation 1,3-dibromo-5,5-dimethylhydantoin of enhanced properties
US20050049420A1 (en) * 2000-01-18 2005-03-03 Elnagar Hassan Y. Process for producing N-halogenated organic compounds
US7999118B2 (en) * 2000-01-18 2011-08-16 Albemarle Corporation Process for producing N-halogenated hydantoins
CA2401571A1 (en) * 2000-02-29 2001-09-07 Ilya Avrutov Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same
US20030099715A1 (en) * 2000-03-28 2003-05-29 Schwarz Franz Xaver Granulated particles with masked taste
US6551617B1 (en) 2000-04-20 2003-04-22 Bristol-Myers Squibb Company Taste masking coating composition
DE60128215T2 (de) 2000-04-20 2008-01-10 Novartis Ag Beschichtungszusammensetzung zur geschmacksmaskierung
US7223421B2 (en) * 2000-06-30 2007-05-29 Mcneil-Ppc, Inc. Teste masked pharmaceutical particles
DE60115465T2 (de) 2000-08-29 2006-08-03 Nobex Corp. Immunoregulierende verbindungen, deren derivate und ihre verwendung
CA2359812C (en) * 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
US20020119196A1 (en) * 2000-12-21 2002-08-29 Narendra Parikh Texture masked particles containing an active ingredient
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
US20030077365A1 (en) * 2001-06-28 2003-04-24 Howarth Jonathan N. Environmentally-friendly microbiological and microbiocidal control in aqueous systems
US6919364B2 (en) * 2001-06-28 2005-07-19 Solution Biosciences, Inc. Microbiological control in animal processing
US6986910B2 (en) * 2001-06-28 2006-01-17 Albemarle Corporation Microbiological control in poultry processing
US8048924B2 (en) 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
GB0123400D0 (en) 2001-09-28 2001-11-21 Novartis Ag Organic compounds
US8309118B2 (en) * 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
FR2830447B1 (fr) * 2001-10-09 2004-04-16 Flamel Tech Sa Forme galenique orale microparticulaire pour la liberation retardee et controlee de principes actifs pharmaceutiques
US8101209B2 (en) * 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
JP4709486B2 (ja) * 2001-10-09 2011-06-22 アルベマール・コーポレーシヨン 産業用水システム中のバイオフィルムの抑制
US20030118329A1 (en) * 2001-12-21 2003-06-26 Pere Obrador Video indexing using high resolution still images
JP4619658B2 (ja) * 2002-03-12 2011-01-26 富山化学工業株式会社 快い味の経口懸濁液および方法
WO2003084518A2 (fr) 2002-04-09 2003-10-16 Flamel Technologies Suspension orale de microcapsules de principes actifs
CA2480824A1 (fr) * 2002-04-09 2003-10-16 Flamel Technologies Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee d'amoxicilline
US6958161B2 (en) * 2002-04-12 2005-10-25 F H Faulding & Co Limited Modified release coated drug preparation
US7429619B2 (en) * 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
AU2003272601B2 (en) * 2002-09-20 2009-05-07 Alpharma Pharmaceuticals, Llc Sustained-release opioid formulations and methods of use
US20060073216A1 (en) * 2002-12-26 2006-04-06 Solution Biosciences, Inc. Compositions and methods for control of bovine mastitis
US8367111B2 (en) * 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US20040265446A1 (en) * 2003-06-24 2004-12-30 Mcnaughton James L. Microbiocidal control in the processing of poultry
US7901276B2 (en) 2003-06-24 2011-03-08 Albemarle Corporation Microbiocidal control in the processing of meat-producing four-legged animals
US20040265445A1 (en) * 2003-06-24 2004-12-30 Liimatta Eric W. Microbiocidal control in the processing of poultry
US7632521B2 (en) * 2003-07-15 2009-12-15 Eurand, Inc. Controlled release potassium chloride tablets
US7417037B2 (en) * 2004-01-20 2008-08-26 The Board Of Regents Of The University Of Oklahoma Compositions and methods of treatment for inflammatory diseases
DK1773767T3 (en) 2004-07-07 2016-03-21 Biocon Ltd Synthesis of azo bound in immune regulatory relations
US8747895B2 (en) * 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
GB2419094A (en) 2004-10-12 2006-04-19 Sandoz Ag Pharmaceutical composition of unpleasnt tasing active substances
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
US20060105039A1 (en) 2004-10-21 2006-05-18 Jin-Wang Lai Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
JP2007031407A (ja) 2005-07-29 2007-02-08 Shin Etsu Chem Co Ltd 低置換度セルロースエーテル含有コーティング用組成物及び不快な味が隠蔽されたフィルムコーティング製剤
TWI407913B (zh) * 2005-12-01 2013-09-11 Albemarle Corp 加工處理四腳屠宰動物及/或衍生自四腳屠宰動物之生肉品之方法
US20070190141A1 (en) * 2006-02-16 2007-08-16 Aaron Dely Extended release opiate composition
WO2008051759A1 (en) 2006-10-20 2008-05-02 Mcneil-Ppc, Inc. Acetaminophen / ibuprofen combinations
AU2007308986A1 (en) * 2006-10-25 2008-05-02 Mcneil-Ppc, Inc. Ibuprofen composition
CN101380474B (zh) * 2007-09-06 2012-07-25 北京大学 用于口服制剂的pH敏感性固体药物组合物及制备方法
KR101704156B1 (ko) * 2008-11-25 2017-02-07 미쓰비시 타나베 파마 코퍼레이션 구강 내 속붕괴성정을 제조하기 위한 혼합물
CA2782285A1 (en) 2009-12-02 2011-06-09 Luigi Mapelli Fexofenadine microcapsules and compositions containing them
WO2011085181A1 (en) * 2010-01-08 2011-07-14 Eurand, Inc. Taste masked topiramate composition and an orally disintegrating tablet comprising the same
EP2719377B1 (en) * 2011-06-10 2018-04-18 Nipro Corporation Method for producing orodispersible tablets
WO2014047001A1 (en) 2012-09-18 2014-03-27 Mcneil-Ppc, Inc. Low melting propionic acid derivative particles for use in oral dosage forms
AU2013318360A1 (en) 2012-09-18 2015-03-26 Mcneil-Ppc, Inc. Sustained release oral dosage forms comprising low melting propionic acid derivative particles
US9820894B2 (en) 2013-03-22 2017-11-21 The Procter & Gamble Company Disposable absorbent articles
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
HUE063849T2 (hu) * 2015-12-28 2024-02-28 Ssp Co Ltd Japan Tömörített gyógyszerészeti készítmény
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
US10828208B2 (en) 2016-11-21 2020-11-10 The Procte & Gamble Company Low-bulk, close-fitting, high-capacity disposable absorbent pant

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
JPS5858145A (ja) * 1981-10-05 1983-04-06 Tanabe Seiyaku Co Ltd 速放性マイクロカプセル
FR2514261B1 (fr) * 1981-10-08 1986-08-22 Aec Chim Organ Biolog Nouvelle composition pour l'enrobage des aliments et des medicaments et granules ainsi enrobes
US4894240A (en) * 1983-12-22 1990-01-16 Elan Corporation Plc Controlled absorption diltiazem formulation for once-daily administration
DE3440288A1 (de) * 1984-11-05 1986-05-07 Gergely, Gerhard, Dr.-Ing., Wien Pharmazeutische zubereitung mit einem gehalt an mindestens einer schleimhautreizenden substanz oder dergleichen, insbesondere profen, sowie verfahren zu ihrer herstellung

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111388444A (zh) * 2020-03-18 2020-07-10 北京鑫开元医药科技有限公司 一种罗红霉素颗粒及其制备方法

Also Published As

Publication number Publication date
JP3193041B2 (ja) 2001-07-30
WO1991016043A1 (en) 1991-10-31
DE69100991D1 (de) 1994-02-24
NZ237824A (en) 1992-03-26
ATE99927T1 (de) 1994-01-15
ES2048594T3 (es) 1994-03-16
IE64274B1 (en) 1995-07-26
US5409711A (en) 1995-04-25
KR0164863B1 (ko) 1999-01-15
DE69100991T2 (de) 1994-05-05
AU7681291A (en) 1991-11-11
EP0477333B1 (en) 1994-01-12
RU2085190C1 (ru) 1997-07-27
IT9020055A0 (it) 1990-04-17
AU635133B2 (en) 1993-03-11
JPH05500674A (ja) 1993-02-12
PT97369A (pt) 1991-12-31
KR920702618A (ko) 1992-10-06
IT9020055A1 (it) 1991-10-17
DK0477333T3 (da) 1994-03-14
HK12495A (en) 1995-02-03
IE911272A1 (en) 1991-10-23
EP0477333A1 (en) 1992-04-01
CA2058946C (en) 2001-11-20
SA99191025A (ar) 2005-12-03
PT97369B (pt) 1998-08-31
ZA912793B (en) 1992-12-30
CA2058946A1 (en) 1991-10-18

Similar Documents

Publication Publication Date Title
IT1246383B (it) Metodo per il mascheramento del sapore di farmaci
GR3001238T3 (en) Process for the preparation of an administration and dosage for drugs, reagents or other active substances
ES2174849T3 (es) Composiciones farmaceuticas con sabor agradable.
PT723437E (pt) Preparacao farmaceutica por unidades multiplas contendo um inibidor da bomba de protoes
RU94045950A (ru) Фармацевтический препарат и способ его приготовления
HUT56267A (en) Process for producing pharmaceutical compositions having controlled release of active ingredient
SE9600073D0 (sv) Multiple unit dosage form
ES2152485T3 (es) Procedimiento para preparar comprimidos que contienen amoxicilina y clavulanato recubiertos de una pelicula polimerica acuosa.
ATE198152T1 (de) Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
EP0382077A3 (de) Diarylsubstituierte heterocyclische Verbindung, ihre Herstellung und Arzneimittel und Kosmetika daraus
TR199701294T1 (xx) Amoksisilin ve klavulanik asitten olu�an terkip.
IT1153487B (it) Prodotti farmaceutici in forma-ritardo e procedimento per ottenerli
ATE139690T1 (de) Ein ibuprofen enthaltendes akut-arzneimittel und seine verwendung
DE68917937D1 (de) Verbindungen mit magensäureinhibitorwirkung und verfahren zur herstellung.
DK0615443T3 (da) Lægemiddel i akut virksom form indeholdende Flurbiprofen og anvendelse deraf
IE32245L (en) Benzodiazepines
GB2333042A (en) Colonic delivery of weak acid drugs
EE03954B1 (et) Toimeaine pärsitud vabanemisega karbamasepiini ravimvormi valmistamise meetod
DE59306983D1 (de) Arzneimittel zur verhinderung der toleranzentwicklung während der behandlung mit benzodiazepin-rezeptor-bindenden wirkstoffen
HUP9802005A2 (hu) Nátrium/hidrogén-csere inhibitorok alkalmazása különböző anyagok által a szívre gyakorolt nem kívánt hatások csökkentésére alkalmas gyógyszerkészítmények előállítására
JO1881B1 (en) Formula II for multi unit disc calibration
TH21670B (th) ยาเม็ดที่เคลือบด้วยโพลิเมอร์ ประกอบด้วยอามอกซีซิลลินและคลาวูลาเนท
RU93042104A (ru) Противокашлевая композиция, содержащая декстрометорфан, способ ее применения

Legal Events

Date Code Title Description
0001 Granted